Day: May 9, 2022

Form 8.3 – Shaftesbury PLC

Written by Customer Service on May 9, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Investec Wealth & Investment Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeShaftesbury Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Capital increase in GreenMobility as a result of exercise of warrants

Written by Customer Service on May 9, 2022. Posted in Public Companies.

Company Announcement no. 112 – 2022Copenhagen, May 9th, 2022 Capital increase in GreenMobility as a result of exercise of warrants GreenMobility A/S (the “Company) has increased its number of shares by 25,632 shares with a nominal value of DKK 0.40 each, corresponding to an increase in share capital of nominally DKK 10,252.80 as a consequence of exercise of 25,632 warrants by certain current and former employees in accordance with article 4.8 and 4.8.1 and Appendix 1 and 2 of the Company’s Articles of Association. The capital increase is effected without any pre-emptive rights for the existing shareholders of the Company. The shares have been subscribed for in cash at an exercise price of DKK 1 per share of nominally DKK 0.40 in connection with the exercise of warrants in accordance with the terms set out in the warrant program. The new...

Gofore Plc’s Business Review 1-30 April, 2022: Gofore in good growth form – New contracts with e.g. Tax Administration and City of Helsinki

Written by Customer Service on May 9, 2022. Posted in Public Companies.

GOFORE PLC STOCK EXCHANGE RELEASE 9 MAY, 2022 AT 2.15 P.M. EET INSIDER INFORMATION Gofore Plc’s Business Review 1 – 30 April, 2022: Gofore in good growth form – New contracts with e.g. Tax Administration and City of Helsinki Gofore’s net sales in April 2022 were 11.5 million euros (8.5 million euros in April 2021). The consolidated pro forma net sales for the last 12-month period (LTM) in February amounted to 125.0 million euros. The Group employed a total of 1,056 people (791 people) at the end of the period. CEO Mikael Nylund comments: ”The strong growth we’ve had since the beginning of the year also continued in April. Our sales team kept busy, succeeding and winning significant new projects focused on digitalization. We agreed with the Finnish tax administration on a 2.5-million-euro contract on expert services in 2022-2024...

NFI awarded new contract by MDOT Maryland Transit Administration for seven zero-emission buses

Written by Customer Service on May 9, 2022. Posted in Public Companies.

ST. CLOUD, Minn., May 09, 2022 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that its subsidiary New Flyer of America Inc. (“New Flyer”) has been awarded a contract from the Maryland Department of Transportation Maryland Transit Administration (“MDOT MTA”) to provide seven zero-emission buses as the agency begins the transition to a zero-emission bus fleet. Included in the contract are three sixty-foot zero-emission, battery-electric Xcelsior CHARGE NG™ heavy-duty transit buses (six equivalent units or “EUs”), and four forty-foot battery-electric Xcelsior CHARGE NG™ transit buses (four EUs) for a total of 10 EUs. The MDOT MTA is one of the largest multi-modal transit systems in the...

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

Written by Customer Service on May 9, 2022. Posted in Public Companies.

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”, or “the Company”) (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s request for a Type C meeting to review the clinical trial protocol for its Phase 3 study of apabetalone in high-risk COVID-19 outpatients. The meeting is scheduled for early August. In response to the transformation of the COVID-19 pandemic, advancement to the Phase 3 trial will target outpatients with multiple risk factors for serious outcomes, focusing where apabetalone has the greatest potential to impact patient outcomes. Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program. By targeting...

Flow Capital Announces a Follow-on Investment in Echobox

Written by Customer Service on May 9, 2022. Posted in Public Companies.

TORONTO, May 09, 2022 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital”) announces that is has closed a third tranche investment in Echobox Ltd. (“Echobox”). Echobox is a leading AI platform providing machine learning-based automation solutions to the global publishing industry. Businesses around the world automate the distribution of over 40 million stories each year with Echobox. “Echobox has a proven product-market fit that is enabling traditional publishers to thrive in the digital social age. We are excited to be extending our support for them as they continue their impressive revenue growth and rapid global expansion. This follow-on investment further demonstrates our ability to identify and fund high performance, high growth companies” commented Alex Baluta, Chief Executive Officer of Flow Capital. Flow Capital...

Statkraft AS: Release of first quarter results 2022

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

Statkraft discloses first quarter results 2022 on Wednesday 11 May 2022 at 08:00 a.m. CEST. The material will be available on Statkraft’s website www.statkraft.com/ir and Oslo Stock Exchange’s news service www.newsweb.no. Live webcast09:00 a.m. CEST: Statkraft presents the results in a live webcast at www.statkraft.com. The presentation will be held in English and is open for investors, analysts and media at Statkraft’s head office, Lilleakerveien 6, Oslo. To attend the presentation in Oslo, please send your registration to arild.ratikainen@statkraft.com. Contact:Arild Ratikainen, Investor Contact, tlf.: +47 971 74 132, e-mail: arild.ratikainen@statkraft.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2022

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

– Cash runway extended into 2024 – – Strengthened financial position with achievement of $30 million milestone from GlaxoSmithKline and $21 million raised in the quarter through ATM facility – – Expanding open label lead-in for SRF388 in first-line hepatocellular carcinoma (HCC), with initial data expected in the first half of 2023 – – New SRF388 clinical data to be presented at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, reported financial results and corporate highlights for the first quarter of 2022 as well as upcoming anticipated corporate milestones. “The first quarter of 2022 marked the...

Form 8.3 – [RWS Holdings plc – 06 05 2022] – (CGWL)

Written by Customer Service on May 9, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree RWS HOLDINGS PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results

Written by Customer Service on May 9, 2022. Posted in Earnings Releases And Operating Results.

FDA review of NDA for FT218 continues; launch readiness preparations on-track to support potential commercial launchPresented interim results from ongoing RESTORE open-label extension / switch study of FT218 highlighting overwhelming patient preference for the once-at-bedtime dosing regimen and characterizing the burden associated with the second dose currently required for twice-nightly oxybatesManagement to host a conference call today at 8:30 a.m. ETDUBLIN, Ireland, May 09, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today provided a corporate update, and announced its financial results for the first quarter ended March 31, 2022. “As our NDA for FT218 continues in late-stage review, we stand at a pivotal moment for...

Day: May 9, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice